Michael P. O’Donnell

3.4k total citations
51 papers, 2.7k citations indexed

About

Michael P. O’Donnell is a scholar working on Nephrology, Surgery and Physiology. According to data from OpenAlex, Michael P. O’Donnell has authored 51 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Nephrology, 14 papers in Surgery and 9 papers in Physiology. Recurrent topics in Michael P. O’Donnell's work include Chronic Kidney Disease and Diabetes (12 papers), Renal Diseases and Glomerulopathies (9 papers) and Cholesterol and Lipid Metabolism (7 papers). Michael P. O’Donnell is often cited by papers focused on Chronic Kidney Disease and Diabetes (12 papers), Renal Diseases and Glomerulopathies (9 papers) and Cholesterol and Lipid Metabolism (7 papers). Michael P. O’Donnell collaborates with scholars based in United States, France and South Korea. Michael P. O’Donnell's co-authors include William F. Keane, Bertram L. Kasiske, Margot P. Cleary, B L Kasiske, Bertram L. Kasiske, Frank Daniels, Alva G. Noel, J. Hugh Devitt, W. F. Keane and Melissa J. Burne and has published in prestigious journals such as Journal of Clinical Investigation, American Journal of Clinical Nutrition and Diabetes.

In The Last Decade

Michael P. O’Donnell

50 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael P. O’Donnell United States 25 836 692 521 474 400 51 2.7k
Vardaman M. Buckalew United States 32 884 1.1× 269 0.4× 467 0.9× 840 1.8× 828 2.1× 93 3.1k
Hans Herlitz Sweden 30 496 0.6× 495 0.7× 745 1.4× 428 0.9× 1.1k 2.6× 155 2.9k
David B. Case United States 30 211 0.3× 694 1.0× 521 1.0× 706 1.5× 1.6k 3.9× 62 3.3k
Helmer Ring‐Larsen Denmark 31 522 0.6× 1.4k 2.0× 212 0.4× 139 0.3× 397 1.0× 94 4.1k
Masahiro Nezu Japan 13 1.1k 1.4× 554 0.8× 319 0.6× 901 1.9× 405 1.0× 26 3.0k
J. I. S. Robertson United Kingdom 27 204 0.2× 426 0.6× 833 1.6× 341 0.7× 826 2.1× 75 2.3k
Giacomo Deferrari Italy 40 2.3k 2.8× 575 0.8× 1.1k 2.1× 721 1.5× 2.1k 5.3× 160 5.4k
Gregorio Brevetti Italy 31 169 0.2× 1.6k 2.4× 469 0.9× 378 0.8× 1.2k 3.0× 82 3.1k
Mias Pretorius United States 27 330 0.4× 424 0.6× 252 0.5× 177 0.4× 707 1.8× 59 1.7k
Jean Ribstein France 27 934 1.1× 547 0.8× 618 1.2× 219 0.5× 1.3k 3.3× 144 2.8k

Countries citing papers authored by Michael P. O’Donnell

Since Specialization
Citations

This map shows the geographic impact of Michael P. O’Donnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. O’Donnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. O’Donnell more than expected).

Fields of papers citing papers by Michael P. O’Donnell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael P. O’Donnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. O’Donnell. The network helps show where Michael P. O’Donnell may publish in the future.

Co-authorship network of co-authors of Michael P. O’Donnell

This figure shows the co-authorship network connecting the top 25 collaborators of Michael P. O’Donnell. A scholar is included among the top collaborators of Michael P. O’Donnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael P. O’Donnell. Michael P. O’Donnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
O’Donnell, Michael P., et al.. (2011). Integrating Wellness into Hospital Systems. American Journal of Health Promotion. 26(2). TAHP1–TAHP14. 3 indexed citations
3.
Nemoto, Takashi, Melissa J. Burne, Frank Daniels, et al.. (2001). Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure. Kidney International. 60(6). 2205–2214. 75 indexed citations
4.
Jee, Sun Ha, et al.. (2001). The Relationship between Modifiable Health Risks and Future Medical Care Expenditures: The Korea Medical Insurance Corporation (KMIC) Study. American Journal of Health Promotion. 15(4). 244–255. 15 indexed citations
5.
Massy, Ziad A., Youngki Kim, Carlos Guijarro, et al.. (2000). Low-Density Lipoprotein-Induced Expression of Interleukin-6, a Marker of Human Mesangial Cell Inflammation: Effects of Oxidation and Modulation by Lovastatin. Biochemical and Biophysical Research Communications. 267(2). 536–540. 58 indexed citations
6.
O’Donnell, Michael P.. (2000). Renal tubulointerstitial fibrosis. Postgraduate Medicine. 108(1). 159–172. 15 indexed citations
7.
Massy, Ziad A., Carlos Guijarro, Michael P. O’Donnell, et al.. (1999). The central role of nuclear factor-κB in mesangial cell activation. Kidney International. 56. S76–S79. 58 indexed citations
8.
Devitt, J. Hugh, et al.. (1998). Gas leak and gastric insufflation during controlled ventilation: face maskversus laryngeal mask airway. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 45(3). 206–211. 91 indexed citations
9.
O’Donnell, Michael P., et al.. (1997). Isoprenoids, Ras and Proliferative Glomerular Disease. Contributions to nephrology. 120. 219–227. 1 indexed citations
10.
Guijarro, Carlos, Yunjeong Kim, B.L. Kasiske, et al.. (1997). Central Role of the Transcription Factor Nuclear Factor-κB in Mesangial Cell Production of Chemokines. Contributions to nephrology. 120. 210–218. 10 indexed citations
11.
Smythe, Maureen A., et al.. (1996). Patient-Controlled Analgesia versus Patient-Controlled Analgesia plus Continuous Infusion after Hip Replacement Surgery. Annals of Pharmacotherapy. 30(3). 224–227. 19 indexed citations
12.
Keane, W. F., Bertram L. Kasiske, Michael P. O’Donnell, & Young‐Ki Kim. (1993). Hypertension, Hyperlipidemia, and Renal Damage. American Journal of Kidney Diseases. 21(5). 43–50. 27 indexed citations
13.
Kasiske, Bertram L., Michael P. O’Donnell, Hyun Jung Lee, Youngki Kim, & W. F. Keane. (1991). Impact of dietary fatty acid supplementation on renal injury in obese Zucker rats. Kidney International. 39(6). 1125–1134. 35 indexed citations
14.
O’Donnell, Michael P., et al.. (1990). High protein intake accelerates glomerulosclerosis independent of effects on glomerular hemodynamics. Kidney International. 37(5). 1263–1269. 21 indexed citations
15.
Keane, William F., Michael P. O’Donnell, Bertram L. Kasiske, & Paul G. Schmitz. (1990). Lipids and the progression of renal disease.. PubMed. 1(5 Suppl 2). S69–74. 21 indexed citations
16.
Kasiske, Bertram L., Michael P. O’Donnell, Margot P. Cleary, William F. Keane, & F. C. Phillips. (1989). Effects of reduced renal mass on tissue lipids and renal injury in hyperlipidemic rats. Kidney International. 35(1). 40–47. 64 indexed citations
17.
Kasiske, Bertram L., Michael P. O’Donnell, & William F. Keane. (1988). Direct Effects of Altered Temperature on Renal Structure and Function. Kidney & Blood Pressure Research. 11(1-2). 80–88. 3 indexed citations
18.
Kasiske, Bertram L., Michael P. O’Donnell, Margot P. Cleary, & William F. Keane. (1988). Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney International. 33(3). 667–672. 350 indexed citations
19.
Keane, William F., Bertram L. Kasiske, & Michael P. O’Donnell. (1987). The Role of Lipids in Progressive Glomerular Disease. Advances in experimental medicine and biology. 223. 81–87. 14 indexed citations
20.
Kasiske, B.L., et al.. (1986). Effects of carbohydrate restriction on renal injury in the obese Zucker rat. American Journal of Clinical Nutrition. 44(1). 56–65. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vardaman M. Buckalew Breakdown of academic impact, for papers by Hans Herlitz Breakdown of academic impact, for papers by David B. Case Breakdown of academic impact, for papers by Helmer Ring‐Larsen Breakdown of academic impact, for papers by Masahiro Nezu Breakdown of academic impact, for papers by J. I. S. Robertson Breakdown of academic impact, for papers by Giacomo Deferrari Breakdown of academic impact, for papers by Gregorio Brevetti Breakdown of academic impact, for papers by Mias Pretorius Breakdown of academic impact, for papers by Jean Ribstein
Rankless by CCL
2026